Erythromycin - Revision history

Danbot: Remove disease-specific entries now covered by AntibioticDose (1 sections)

2026-03-20T11:08:11Z

Remove disease-specific entries now covered by AntibioticDose (1 sections)

← Older revision		Revision as of 11:08, 20 March 2026
Line 7:		Line 7:
	*250-500mg PO q6h		*250-500mg PO q6h

	~~===Pre-endoscopy===~~
	*3mg/kg IV over 20-30min, 30-90min prior to endoscopy
	**Achieves endoscopy conditions equal to lavage<ref>Pateron D, et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Ann Emerg Med. 2011; 57(6):582-589.</ref>

2026-03-20T02:38:44Z

Restore original dosing content alongside dynamic SMW tables

← Older revision		Revision as of 02:38, 20 March 2026
Line 5:		Line 5:

	==Adult Dosing==		==Adult Dosing==
			*250-500mg PO q6h

			===Pre-endoscopy===
			*3mg/kg IV over 20-30min, 30-90min prior to endoscopy
			**Achieves endoscopy conditions equal to lavage<ref>Pateron D, et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Ann Emerg Med. 2011; 57(6):582-589.</ref>


	===Indications by Disease===		===Indications by Disease===
	{{#ask: [[Has DrugName::Erythromycin]] [[Has Population::Adult]]		{{#ask: [[Has DrugName::Erythromycin]] [[Has Population::Adult]]
	\|?Treats disease=Disease		\|?Treats disease=Disease
	\|?Has Dose=Dose		\|?Has Dose=Dose
	\|?Has Context=Context		\|?Has Context=Context
	\|format=table		\|format=table
	\|limit=50		\|limit=50
	\|mainlabel=-		\|mainlabel=-
	\|headers=show		\|headers=show
	\|sort=Treats disease		\|sort=Treats disease
	}}		}}

	==Pediatric Dosing==		==Pediatric Dosing==
			*Mild-moderate infections: 30-50 mg/kg/day PO divided q6-8hr
			*Severe infection: 60-100 mg/kg/day PO divided q6-8hr


	===Indications by Disease===		===Indications by Disease===
	{{#ask: [[Has DrugName::Erythromycin]] [[Has Population::Pediatric]]		{{#ask: [[Has DrugName::Erythromycin]] [[Has Population::Pediatric]]
	\|?Treats disease=Disease		\|?Treats disease=Disease
	\|?Has Dose=Dose		\|?Has Dose=Dose
	\|?Has Context=Context		\|?Has Context=Context
	\|format=table		\|format=table
	\|limit=50		\|limit=50
	\|mainlabel=-		\|mainlabel=-
	\|headers=show		\|headers=show
	\|sort=Treats disease		\|sort=Treats disease
	}}		}}

2026-03-20T01:52:39Z

Replace manual dosing with dynamic SMW tables (Adult + Pediatric)

← Older revision		Revision as of 01:52, 20 March 2026
Line 5:		Line 5:

	==Adult Dosing==		==Adult Dosing==
	*250-500mg PO q6h		===Indications by Disease===
			{{#ask: [[Has DrugName::Erythromycin]] [[Has Population::Adult]]
	===~~Pre-endoscopy~~===		\|?Treats disease=Disease
	*3mg/kg IV over 20-30min, 30-90min prior to endoscopy		\|?Has Dose=Dose
	**Achieves endoscopy conditions equal to lavage<ref>Pateron D, et al. Erythromycin ~~infusion or gastric lavage for upper gastrointestinal bleeding~~: ~~a multicenter randomized controlled trial. Ann Emerg Med. 2011; 57(6)~~:~~582~~-~~589.</ref>~~		\|?Has Context=Context
			\|format=table
			\|limit=50
			\|mainlabel=-
			\|headers=show
			\|sort=Treats disease
			}}

	==Pediatric Dosing==		==Pediatric Dosing==
	*Mild-moderate infections: ~~30-~~50 ~~mg/kg/day PO divided q6~~-~~8hr~~		===Indications by Disease===
	*Severe infection: 60-100 mg/kg/day PO divided q6-8hr		{{#ask: [[Has DrugName::Erythromycin]] [[Has Population::Pediatric]]
			\|?Treats disease=Disease
			\|?Has Dose=Dose
			\|?Has Context=Context
			\|format=table
			\|limit=50
			\|mainlabel=-
			\|headers=show
			\|sort=Treats disease
			}}

	==Special Populations==		==Special Populations==

2025-07-18T16:34:15Z

2019-09-22T19:32:30Z

← Older revision		Revision as of 19:32, 22 September 2019
Line 1:		Line 1:
	==General==		==General==
	*Type:		*Type: [[Macrolide]]
	*Dosage Forms:		*Dosage Forms: PO, IV, topical
	*Common Trade Names:		*Common Trade Names:

	==Adult Dosing==		==Adult Dosing==
			*250-500mg PO q6h

	===Pre-endoscopy===		===Pre-endoscopy===
	*3mg/kg IV over 20-30min, 30-90min prior to endoscopy		*3mg/kg IV over 20-30min, 30-90min prior to endoscopy
Line 10:		Line 12:

	==Pediatric Dosing==		==Pediatric Dosing==
			*Mild-moderate infections: 30-50 mg/kg/day PO divided q6-8hr
			*Severe infection: 60-100 mg/kg/day PO divided q6-8hr

	==Special Populations==		==Special Populations==
	*Pregnancy:		*[[Drug Ratings in Pregnancy\|Pregnancy Rating]]: B
	*Lactation:		*[[Lactation risk categories\|Lactation risk]]: AAP categorizes as compatible with breastfeeding
	*Renal Dosing		*Renal Dosing: No adjustment
	**Adult		*Hepatic Dosing: Use caution
	**Pediatric
	*Hepatic Dosing
	**Adult
	**Pediatric

	==Contraindications==		==Contraindications==
Line 27:		Line 27:
	==Adverse Reactions==		==Adverse Reactions==
	===Serious===		===Serious===
			*Torsades, ventricular dysrhythmias
			*Pseudomembranous colitis
			*Hypertrophic pyloric stenosis
			*Seizures

	===Common===		===Common===
Line 169:		Line 173:
	<references/>		<references/>
	[[Category:Pharmacology]]		[[Category:Pharmacology]]
			[[Category:ID]]

2017-11-17T22:04:43Z

Text replacement - "-->" to "→"

← Older revision		Revision as of 22:04, 17 November 2017
Line 39:		Line 39:
	*Metabolism: Liver		*Metabolism: Liver
	*Excretion: Bile/Renal		*Excretion: Bile/Renal
	*Mechanism of Action: Binds to 50S ribosomal unit ~~-->~~ inhibiting protein synthesis		*Mechanism of Action: Binds to 50S ribosomal unit → inhibiting protein synthesis

	==[[Antibiotic Sensitivities]]<ref>Sanford Guide to Antimicrobial Therapy 2014</ref>==		==[[Antibiotic Sensitivities]]<ref>Sanford Guide to Antimicrobial Therapy 2014</ref>==

2017-10-24T23:59:27Z

Text replacement - "==References== <references/>" to "==References== <references/>"

2017-10-13T15:03:21Z

Contraindications

2017-10-13T15:02:41Z

Common

2017-10-13T15:01:34Z

Pharmacology

← Older revision		Revision as of 15:01, 13 October 2017
Line 30:		Line 30:

	==Pharmacology==		==Pharmacology==
	*Half-life:		*Half-life: 2 hours
	*Metabolism:		*Metabolism: Liver
	*Excretion:		*Excretion: Bile/Renal
	*Mechanism of Action:		*Mechanism of Action: Binds to 50S ribosomal unit --> inhibiting protein synthesis

	==[[Antibiotic Sensitivities]]<ref>Sanford Guide to Antimicrobial Therapy 2014</ref>==		==[[Antibiotic Sensitivities]]<ref>Sanford Guide to Antimicrobial Therapy 2014</ref>==